HPV Infection and Cervical Lesions in HIV Infected Women in Thailand: A Prospective Study (PapilloV)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
![](https://webarchive.library.unt.edu/web/20130228113844im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
HIV-infected women are at high risk of developing cervical cancer. This is a 3-year cohort study nested in the already existing Program for HIV Prevention and Treatment (PHPT) cohort of HIV-infected patients in Thailand (NCT 00433030). The main objective is to assess the prevalence, incidence, and clearance rate of HPV cervical infection and associated cervical lesion. The study will also provide the distribution of the HPV genotypes involved as well as other risk factors of cervical lesions. HIV-infected women receiving antiretrovirals, older than18 years of age, followed in the PHPT cohort or in the same hospitals are proposed to participate. An annual gynecological examination with a Pap-smear and a sampling for HPV testing is performed. Women with abnormal Pap-smear or with High-Risk HPV (HR-HPV) infection receive a more intensive follow-up with a colposcopy and a biopsy if necessary. Treatment is provided according to the National Guidelines.
Condition |
---|
Cervical Cancer |
Study Type: | Observational |
Study Design: | Observational Model: Cohort Time Perspective: Prospective |
Official Title: | HPV Infection and Cervical Lesions in HIV Infected Women in Thailand |
- High risk HPV infection [ Time Frame: January 2015 ] [ Designated as safety issue: No ]
- Cervical lesions: cytological abnormalities of squamous cells: ASC-US, ASC-H, LSIL, HSIL or SCC (ASCUS +) or glandular cells (AGC, AGC favor neoplasia or adenocarcinoma) [ Time Frame: Up to 3 years ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples With DNA
Cervical secretions
Estimated Enrollment: | 884 |
Study Start Date: | February 2012 |
Estimated Study Completion Date: | January 2015 |
Estimated Primary Completion Date: | January 2015 (Final data collection date for primary outcome measure) |
Title of the study: HPV Infection and Cervical Lesions in HIV infected Thai Women - A Prospective Study Country: Thailand Study period: 3 years Planned enrollment duration: 6 months
Primary objectives:
- To evaluate the prevalence, the incidence, the persistence rate and the clearance rate of HPV cervical infection, of genotypes involved and of multiple infections.
- To evaluate the prevalence, the incidence, the progression rate and the regression rate of cyto-histological abnormalities
- To assess the efficacy of different screening algorithms using pap smear alone, pap-smear associated with HPV and HPV alone
Secondary objectives:
- To determine the risk factors of high grade lesions (Cervical intraepithelial neoplasia (CIN)2 or higher) in HIV infected Thai women
- To evaluate cyto-histology performances at different hospital levels Methods: A multicenter prospective cohort study nested in the PHPT cohort.
Inclusion criteria: HIV infected women, older than18 years of age, followed in the PHPT cohort or in the same hospitals.
Exclusion criteria: Virginity, total hysterectomy, pregnancy after 3rd month, inclusion in a HPV vaccination trial Planned number of patients to be enrolled: 884
Follow-up procedures:
Annual gynecological examination with a Pap-smear and a sampling for HPV testing is planned.
Women with abnormal Pap-smear or with High-Risk HPV (HR-HPV) infection will be referred to a colposcopist.
In case of abnormalities at the colposcopy, a biopsy will be performed.
- If the biopsy is normal or shows a CIN1, the women will be referred for a new colposcopic examination 6 months later.
- If the biopsy shows CIN2 or more, treatment will be provided -LEEP or conisation, or hysterectomy, and the women will be referred for a new colposcopic examination 6 months later.
Biological and pathological procedures:
- Pap-smears will be read by local pathologists in participating hospital.
- Biopsies will be read by local pathologists in participating hospital.
- HPV tests will all be performed in the PHPT virological laboratory in Chiang Mai.
Statistical methodology:
Descriptive statistics, univariate and multivariate analyses.
![](https://webarchive.library.unt.edu/web/20130228113844im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
HIV-infected women followed in the PHPT cohort
Inclusion Criteria:
- HIV infected women, older than 18 years of age, followed in the PHPT cohort
Exclusion Criteria:
- Virginity, total hysterectomy, pregnancy after 3rd month, inclusion in a HPV vaccination trial
![](https://webarchive.library.unt.edu/web/20130228113844im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
Contact: Sophie Le Coeur, MD, PhD | +66 (0) 53 819 125 ext 200 | Sophie.LeCoeur@phpt.org |
Thailand | |
Bhumibol Adulyadej Hospital | Recruiting |
Saimai, Bangkok, Thailand | |
Principal Investigator: Sinart Prommas, MD | |
Prapokklao Hospital | Recruiting |
Prapokklao, Muang, Chantaburi, Thailand, 22000 | |
Contact: Prapap Yuthavisuthi, MD yuthavisuthi@gmail.com | |
Principal Investigator: Prapap Yuthavisuthi, MD | |
Nakornping Hospital | Recruiting |
Mae Rim, Chiang Mai, Thailand, 50180 | |
Contact: Prattana Leenasirimakul, MD prattanalee@hotmail.com | |
Principal Investigator: Aram Limtrakul, MD | |
Lamphun Hospital | Recruiting |
Muang, Chiang Mai, Thailand, 51000 | |
Contact: Nuananong Luekamlung, MD nleerayu@yahoo.co.th | |
Principal Investigator: Nuananong Luekamlung, MD | |
Sanpatong Hospital | Recruiting |
Sanpatong, Chiang Mai, Thailand, 20120 | |
Contact: Virat Klinbuayaem, MD 053 825265 kggvirat@hotmail.com | |
Principal Investigator: Virat Klinbuayaem, MD | |
Mae Chan Hospital | Recruiting |
Mae Chan, Chiang Rai, Thailand | |
Contact: Sudanee Buranabanjasatean, MD sudanee2011@windowslive.com | |
Principal Investigator: Sudanee Buranabanjasatean, MD | |
Mae Sai Hospital | Recruiting |
Mae Sai, Chiang Rai, Thailand, 57130 | |
Contact: Rattakarn Paramee, MD prattakarn@yahoo.com | |
Principal Investigator: Rattakarn Paramee, MD | |
Phan Hospital | Recruiting |
Phan, Chiang Rai, Thailand, 57120 | |
Contact: Sookchai Theansavettrakul, MD scthean@gmail.com | |
Principal Investigator: Sookchai Theansavettrakul, MD | |
Chiangrai Prachanukroh Hospital | Recruiting |
Muang, Chiangrai, Thailand | |
Contact: Pacharee Kantipong pachareek@hotmail.com | |
Principal Investigator: Pacharee Kantipong, MD | |
Chonburi Hospital | Recruiting |
Muang, Chonburi, Thailand, 20000 | |
Contact: Chureeratana Bowonwatanuwong, MD Cbowon@chonburi.ksc.co.th | |
Principal Investigator: Nantasak Chotivanich, MD | |
Lampang Hospital | Recruiting |
Muang, Lampang, Thailand, 52000 | |
Contact: Panita Pathipvanich, MD panitapa@yahoo.com | |
Principal Investigator: Panita Pathipvanich, MD | |
Mahasarakam Hospital | Recruiting |
Muang, Mahasarakam, Thailand, 44000 | |
Contact: Suchart Thongpaen, MD SCTP_16@hotmail.com | |
Principal Investigator: Suchart Thongpaen, MD | |
Nakhonpathom Hospital | Recruiting |
Muang, Nakhonpathom, Thailand, 73000 | |
Contact: Rucha Kongpanichkul, MD ruchakong@gmail.com | |
Principal Investigator: Rucha Kongpanichkul, MD | |
Nong Khai Hospital | Recruiting |
Muang, Nong Khai, Thailand | |
Contact: Naruepon Yutthakasemsunt, MD | |
Principal Investigator: Naruepon Yutthakasemsunt, MD | |
Chiang Kham Hospital | Recruiting |
Chiang Kham, Phayao, Thailand, 56110 | |
Contact: Chaiwat Putiyanun, MD putiyanun@hotmail.com | |
Principal Investigator: Chaiwat Putiyanun, MD | |
Buddhachinaraj Hospital | Recruiting |
Muang, Pitsanulok, Thailand | |
Contact: Somboon Tansuphasawasdikul Somboontansuphaswasdikul@yahoo.com | |
Principal Investigator: Somboon Tansuphasawasdikul, MD | |
Ratchaburi Hospital | Recruiting |
Muang, Ratchaburi, Thailand | |
Contact: Pensiriwan Sang-a-gad, MD pensiriwan@yahoo.com | |
Principal Investigator: Pensiriwan Sang-a-gad, MD | |
Rayong Hospital | Recruiting |
Muang, Rayong, Thailand, 21000 | |
Contact: Sukit Banchongkit, MD sbanchongkit@yahoo.com | |
Principal Investigator: Sukit Banchongkit, MD | |
Samutprakarn Hospital | Recruiting |
Pak Nam, Samutprakarn, Thailand | |
Contact: Naree Eiamsirikit, MD phatarapun@yahoo.co.th | |
Principal Investigator: Naree Eiamsirikit, MD | |
Samutsakorn Hospital | Recruiting |
Muang, Samutsakorn, Thailand | |
Contact: Apichat Chutanunta, MD dr.apichati@gmail.com | |
Principal Investigator: Apichat Chutanunta, MD | |
Hat Yai Hospital | Recruiting |
Hat Yai, Songkla, Thailand, 90110 | |
Contact: Tapnarong Jarupanich, MD tapnarong@hotmail.com | |
Principal Investigator: Tapnarong Jarupanich, MD | |
Bhuddasothorn Hospital | Recruiting |
Chachoengsao, Thailand | |
Contact: Pakorn Wittayapraparat pakornwit@hotmail.com | |
Principal Investigator: Pakorn Wittayapraparat, MD | |
Maharat Nakhon Ratchasima Hospital | Recruiting |
Nakhonratchasima, Thailand | |
Contact: Rittha Lertkoonalak, MD KANYAREHAB@hotmail.com | |
Principal Investigator: Rittha Lertkoonalak, MD | |
Phayao Hospital | Recruiting |
Phayao, Thailand, 56000 | |
Contact: Guttiga Halue, MD drgutti@gmail.com | |
Principal Investigator: Guttiga Halue, MD |
Principal Investigator: | Sophie Le Coeur, MD, PhD | Institut National d'Etudes Démographiques |
Principal Investigator: | Gonzague Jourdain, MD, PhD | Institut de Recherche pour le Developpement |
Principal Investigator: | Nicole Ngo-Giang- Huong, PharmaD, PhD | Institut de Recherche pour le Developpement |
Principal Investigator: | Isabelle Heard, MD, PhD | Centre national de réference des papillomavirus humains, Institut Pasteur |
Principal Investigator: | Aram Limtrakul, MD | Nakornping Hospital, Minsitry of Public Health |
Principal Investigator: | Nantasak Chotivanich, MD | Chonburi Hospital, Minsitry of Public Health |
Principal Investigator: | Chaiwat Putiyanun, MD | Chiang Kham Hospital, Ministry of Public Health |
Principal Investigator: | Samreung Rangdaeng, Associate professor | Department of Pathology Faculty of Medicine, Chiang Mai University |
![](https://webarchive.library.unt.edu/web/20130228113844im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
No publications provided
Responsible Party: | Marc Lallemant, Institut de Recherche pour le Developpement |
ClinicalTrials.gov Identifier: | NCT01792973 History of Changes |
Other Study ID Numbers: | PapilloV |
Study First Received: | February 11, 2013 |
Last Updated: | February 13, 2013 |
Health Authority: | Thailand: Ministry of Public Health |
Keywords provided by Institut de Recherche pour le Developpement:
HIV HPV Women |
Thailand Antiretrovirals Cervical cancer |
Additional relevant MeSH terms:
Uterine Cervical Neoplasms Uterine Neoplasms Genital Neoplasms, Female Urogenital Neoplasms Neoplasms by Site |
Neoplasms Uterine Cervical Diseases Uterine Diseases Genital Diseases, Female |
ClinicalTrials.gov processed this record on February 26, 2013